abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Esta página não está disponível em Português e está sendo exibida em English

Artigo

18 Fev 2003

Author:
John Sulston, founding director of the Wellcome Trust Sanger Institute who shared the Nobel Prize for medicine in 2002, in Guardian [UK]

The rich world's patents abandon the poor to die

Non-branded Aids drugs would save a generation in developing countries -...The US, influenced by the pharmaceutical lobby, blocked an agreement at the WTO to lift restrictions on exports of cheap generics to countries that cannot produce affordable versions themselves. What is going wrong? What are we and our companies afraid of?

Linha do tempo